Capital Performance Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,300
Closed -$679K 348
2026
Q1
$679K Sell
2,300
-6
-0.3% -$1.78K 0.05% 174
2025
Q4
$630K Sell
2,306
-39
-2% -$10.6K 0.04% 183
2025
Q3
$634K Sell
2,345
-32
-1% -$8.71K 0.1% 102
2025
Q2
$655K Buy
2,377
+150
+7% +$40.8K 0.13% 85
2025
Q1
$591K Buy
2,227
+231
+12% +$57K 0.13% 83
2024
Q4
$464K Buy
1,996
+853
+75% +$196K 0.15% 61
2024
Q3
$252K Buy
+1,143
New +$237K 0.08% 93

Other funds holding CME

Capital Performance Advisors's CME Position: Q2 2026 in Review

Capital Performance Advisors sold out of CME Group (CME) in Q2 2026, closing a stake of 2,300 shares — an estimated $679K sold.

Capital Performance Advisors first reported a position in CME in Q3 2024 and held it in 7 quarters. The position peaked at $679K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Capital Performance Advisors reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Capital Performance Advisors sold 2,300 CME Group shares in Q2 2026, an estimated $679K.
  • Capital Performance Advisors first reported a position in CME Group in Q3 2024 and held it in 7 quarters.
  • Capital Performance Advisors's CME Group position peaked at $679K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.